Cargando…
Clinical Research of Pulmonary Langerhans Cell Histiocytosis in Children
BACKGROUND: Pulmonary Langerhans cell histiocytosis (PLCH) is an interstitial primary pulmonary disease, characterized by Langerhans cell proliferation. It is easily misdiagnosed in children. This study aimed to characterize the clinical manifestations and features of PLCH by retrospective analysis....
Autores principales: | Wang, Dong, Cui, Lei, Li, Zhi-Gang, Zhang, Li, Lian, Hong-Yun, Ma, Hong-Hao, Zhao, Yun-Ze, Zhao, Xiao-Xi, Wang, Tian-You, Zhang, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071458/ https://www.ncbi.nlm.nih.gov/pubmed/30058575 http://dx.doi.org/10.4103/0366-6999.237400 |
Ejemplares similares
-
Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAF(V600E)-Mutated Langerhans Cell Histiocytosis
por: Yang, Ying, et al.
Publicado: (2021) -
Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis
por: Cui, Lei, et al.
Publicado: (2020) -
Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis
por: Wang, Dong, et al.
Publicado: (2022) -
Cladribine and cytarabine in children refractory high risk multisystem Langerhans cell histiocytosis
por: Wang, Wenqian, et al.
Publicado: (2023) -
Pulmonary langerhans cell histiocytosis
por: Suri, Harpreet S, et al.
Publicado: (2012)